[{"Assets_0_Q2_USD":2533685000.0,"CommonStockSharesOutstanding_0_Q2_shares":48163627.0,"EarningsPerShareBasic_1_Q2_USD":0.99,"EarningsPerShareBasic_2_Q2_USD":1.22,"EarningsPerShareDiluted_1_Q2_USD":0.98,"EarningsPerShareDiluted_2_Q2_USD":1.22,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":31560000.0,"NetIncomeLoss_1_Q2_USD":47498000.0,"NetIncomeLoss_2_Q2_USD":58769000.0,"StockholdersEquity_0_Q2_USD":1843520000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":48303000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":48241000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":48140000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":48104000.0,"Ticker":"LIVN","CIK":"1639691","name":"LIVANOVA PLC","OfficialName":"LivaNova PLC Ordinary Shares","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4559360993.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20170809"}]